Clinical trial
A Trial of Tolerogenic Immunosuppression in Highly Sensitized Renal Transplant…
NCT00407160 · The University of Texas Medical Branch, Galveston, Other · Completed
Key facts
| NCT number | NCT00407160 |
|---|---|
| Title | A Trial of Tolerogenic Immunosuppression in Highly Sensitized Renal Transplant Recipients |
| Official title | Comparison of Two Different Immunosuppression Protocols in Highly Sensitized Renal Transplant Recipients: Campath Induction With Tacrolimus Monotherapy vs Thymoglobulin Induction With Triple Drug Protocol. |
| Lead sponsor | The University of Texas Medical Branch, Galveston, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Kidney Diseases |
| Enrollment | 21 |
| Start date | Aug 1, 2004 |
| Primary completion | Jan 1, 2011 |
| Completion | Jan 1, 2011 |
| First posted | Dec 4, 2006 |
| Last update posted | Mar 4, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: